National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 02:38:04

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67544-061-30	EA - Each	67544-061	c5af9ab2-036a-4513-acb2-28fe0d1260a2	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
67544-061	67544-061-30

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021402-001	SYNTHROID	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-002	SYNTHROID	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-003	SYNTHROID	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-004	SYNTHROID	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-005	SYNTHROID	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-006	SYNTHROID	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-007	SYNTHROID	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-008	SYNTHROID	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-009	SYNTHROID	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-010	SYNTHROID	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-011	SYNTHROID	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24
N021402-012	SYNTHROID	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 24 matching rows.

Application-product, TE code table
Application-product	TE code
N021402-001	AB1
N021402-001	AB2
N021402-002	AB1
N021402-002	AB2
N021402-003	AB1
N021402-003	AB2
N021402-004	AB1
N021402-004	AB2
N021402-005	AB1
N021402-005	AB2
N021402-006	AB1
N021402-006	AB2
N021402-007	AB1
N021402-007	AB2
N021402-008	AB1
N021402-008	AB2
N021402-009	AB1
N021402-009	AB2
N021402-010	AB1
N021402-010	AB2
N021402-011	AB1
N021402-011	AB2
N021402-012	AB1
N021402-012	AB2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 14 · 528 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-005	SYNTHROID	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-006	SYNTHROID	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-007	SYNTHROID	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-008	SYNTHROID	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-009	SYNTHROID	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-010	SYNTHROID	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-011	SYNTHROID	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-012	SYNTHROID	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-005	SYNTHROID	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-006	SYNTHROID	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-007	SYNTHROID	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-008	SYNTHROID	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-009	SYNTHROID	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-010	SYNTHROID	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-011	SYNTHROID	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-012	SYNTHROID	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-005	SYNTHROID	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-006	SYNTHROID	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-007	SYNTHROID	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-008	SYNTHROID	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-009	SYNTHROID	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-010	SYNTHROID	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-011	SYNTHROID	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-012	SYNTHROID	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 27 · 1,056 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	N021402-001	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-001	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-002	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-002	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-003	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-003	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-004	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-004	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-005	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-005	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-006	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-006	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-007	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-007	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-008	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-008	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-009	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-009	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-010	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-010	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-011	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-011	AB2	2	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-012	AB1	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N021402-012	AB2	2	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N021402-001	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-001	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-002	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-002	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-003	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-003	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-004	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-004	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-005	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-005	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-006	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-006	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-007	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-007	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-008	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021402-008	AB2	2	`84e616aacf4f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.